Toronto – The City of Toronto has distributed $4.6 million in grants to support its Vaccine Engagement Teams (VETs) in reducing barriers to COVID-19 vaccines and increasing access and vaccination uptake in equity-deserving communities. Funding will go toward continued equity-based outreach and engagement activities in neighbourhoods and communities that have been hit hardest by the COVID-19 pandemic and remain vulnerable …
KIRKLAND – Pfizer Canada ULC announced today that PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) is now available in Canada for the prevention of pneumonia and invasive pneumococcal disease (including sepsis, meningitis, bacteremic pneumonia, pleural empyema and bacteremia) caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes in the vaccine in adults ages 18 years and older. Approved by Health Canada, PREVNAR …
Toronto – Toronto Public Health (TPH) continues to provide more opportunities for residents ages five and older to receive Covid-19 vaccinations at summer festivals. This week’s vaccination opportunities have something for everyone – furry friends at Paws in the Park, tennis aces at the National Bank Open, flavours of the Caribbean at JerkFest and hot rods at Wheels on Danforth. …
London – AstraZeneca’s Tezspire (tezepelumab) has been recommended for marketing authorisation in the European Union (EU) as an add-on therapy in patients 12 years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another medicinal product for maintenance treatment. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive …
LA – The monkeypox drug is not readily available. The US Food and Drug Administration has not approved tecovirimat — sold under Tpoxx brand for treating monkeypox but the US Centers for Disease Control and Prevention is making the drug available under Strategic National Stockpile. However, people are still facing challenges to get it.
Primary series CDC does not recommend mixing products for your primary series doses. If you received Pfizer-BioNTech or Moderna COVID-19 for the first dose of your primary series, you should get the same product for all following primary series doses. Boosters People ages 18 years and older may get a different product for a booster than they got for their …
Toronto – Team Toronto added 410 COVID-19 vaccination appointments for children ages six months to under five years at five City of Toronto-run immunization clinics. These new appointments are in addition to 2,000 appointments for six-month- to under-five-year-olds added to the provincial booking system. The City will continue to make more appointments available as additional supply is received from the …
Toronto – For the second consecutive week, Team Toronto has delivered more than 45,000 fourth doses – known as second boosters – of COVID-19 vaccine to eligible Torontonians. In the two weeks since the Province of Ontario expanded fourth dose eligibility to people age 18 and older on July 14, 91,045 people in Toronto have received their second booster dose. …
Kirkland – Pfizer Canada and BioNTech filed a New Drug Submission (NDS) with Health Canada for an Omicron-adapted bivalent COVID-19 vaccine candidate, based on the BA.1 sub-lineage, to be administered as a booster dose in individuals 12 years of age and older. This application follows guidance from Health Canada to work towards the introduction of an Omicron-adapted bivalent vaccine candidate …
Toronto – The City of Toronto is encouraging more than 753,000 eligible residents to get their booster dose (third dose) of COVID-19 vaccine to combat variants and best protect themselves. Toronto Public Health (TPH) is hosting many COVID-19 vaccination clinics this week and throughout the long weekend, to help as many residents as possible get their booster dose of the …
World
589,678,215
USA
93,910,150
India
44,161,899
Canada
4,084,728
Pakistan
1,559,929
